mice on day 0 and 7. I.t. instillation of HDM was repeated on day 14 as challenge. 72 h after the last HDM application mice were either sacrificed to obtain BALF cells for FACS analysis, lung sections for histology and mediastinal lymph node cells for allergen re-stimulation to determine Th2 cytokine production, or anesthetized for bronchoalveolar hyperresponsiveness measurement. Control mice received vehicle (PBS) on day 0 and 7 instead of HDM.
BMDC in vitro migration assay
Triplicates of 1x10 5 BMDCs in 100 µl RPMI medium without supplements (Gibco Life Technologies, Carlsbad, CA) were put in a 5 µm transwell insert placed in a 24-well plate (Corning, Amsterdam, Netherlands). Lower compartments were loaded with increasing concentrations of ATP. The plate was incubated at 37°C with 5 % CO 2 for 2 hours. Chemotactic index was calculated by dividing number of cells from each lower compartment by the number of migrated cells in medium control.
Generation of bone marrow derived macrophages (BMDM)
The murine femur and tibia were flushed with DMEM medium containing 10 mM LGlutamin, 10 % FCS (Biocell Laboratories, Rancho Dominguez, CA), and 1 % penicillin/streptomycin to obtain bone marrow cells. 4x10 6 bone marrow cells were incubated at 37°C with 5 % CO 2 in 10 ml DMEM medium supplemented with 100 IU/ml recombinant murine macrophage colony-stimulating factor (M-CSF, Immunotools, Friesoythe, Germany). Additional 5 ml medium supplemented with M-CSF were added on day 3. On day 7 BMDMs were collected and plated in a 24-well plate using 5x10 5 cells per well. BMDMs were activated by adding LPS (3 µg/ml) for 6 h. 
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